Drug intelligence / Profile preview

ketorolac + isopropyl alcohol + lidocaine

Development stage
Unknown
Lead developer
IT3 Medical
Modality
Small Molecules
Administration
Infiltration, Intramuscular, Intravenous, Perineural, Topical
01

Overview

This is a **combination pharmaceutical product** composed of ketorolac (a nonsteroidal anti-inflammatory drug), isopropyl alcohol (an antiseptic/disinfectant), and lidocaine (a local anesthetic). Ketorolac acts by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby blocking prostaglandin synthesis to produce analgesic and anti-inflammatory effects[7]. Lidocaine blocks voltage-gated sodium channels in neuronal membranes, preventing pain signal transmission[8]. Isopropyl alcohol serves primarily as a vehicle and antiseptic but does not contribute a pharmacological effect relevant to analgesia[9]. This combination is used for **local injection or regional anesthesia** where rapid and prolonged pain control is desired, often in procedures such as musculoskeletal biopsies and minor surgeries, with evidence showing superior pain control compared to lidocaine alone during the early postoperative period[1][3].

Brand names
Acunistat-30Acunistat30Acunistat 30Acunistat-60Acunistat60Acunistat 60
Other names
ketorolac tromethamine + isopropyl alcohol + lidocaine hydrochloride
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)NaV alpha (Voltage-gated sodium channel alpha subunit family)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on ketorolac + isopropyl alcohol + lidocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ketorolac + isopropyl alcohol + lidocaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call